Johnson Matthey announces completion of Health sale
1 June 2022
Johnson Matthey Plc (JM), a global leader in sustainable technologies, today announces that that it has completed the sale of its Health business in accordance with the terms of the sale agreement entered into between JM and Altaris Capital Partners ("Altaris"), a leading healthcare investment firm.
The Health business, which has been rebranded as Veranova, was sold for a total consideration of £325 million. As part of the transaction, JM will retain approximately a 30% equity stake in Veranova.
ENDS
Johnson Matthey is a global leader in sustainable technologies that enable a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, energy, chemical processing and making the most efficient use of the planet's natural resources. Today about 15,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information, visit www.matthey.com
Inspiring science, enhancing life
For further information
Media
jmpr@matthey.com
0207 269 8001
Investor Relations
Martin Dunwoodie Director of Investor Relations 0207 269 8241
Louise Curran Senior Investor Relations Manager 0207 269 8235
Carla Fabiano Senior Investor Relations Manager 0207 269 8004
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
